Chemoinformaics analysis of 4-(3-Hydroxypropyl)-2,6-dimethoxyphenol
Molecular Weight | 212.245 | nRot | 5 |
Heavy Atom Molecular Weight | 196.117 | nRig | 6 |
Exact Molecular Weight | 212.105 | nRing | 1 |
Solubility: LogS | -1.815 | nHRing | 0 |
Solubility: LogP | 0.844 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
nHA | 4 | APOL | 32.2467 |
nHD | 2 | BPOL | 19.5233 |
QED | 0.773 |
Synth | 1.897 |
Natural Product Likeliness | 0.86 |
NR-PPAR-gamma | 0.642 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.002 |
Pgp-sub | 0.134 |
HIA | 0.006 |
CACO-2 | -4.386 |
MDCK | 0.0000226 |
BBB | 0.33 |
PPB | 0.494776 |
VDSS | 1.098 |
FU | 0.222935 |
CYP1A2-inh | 0.679 |
CYP1A2-sub | 0.896 |
CYP2c19-inh | 0.103 |
CYP2c19-sub | 0.844 |
CYP2c9-inh | 0.037 |
CYP2c9-sub | 0.678 |
CYP2d6-inh | 0.04 |
CYP2d6-sub | 0.876 |
CYP3a4-inh | 0.048 |
CYP3a4-sub | 0.343 |
CL | 11.293 |
T12 | 0.925 |
hERG | 0.051 |
Ames | 0.013 |
ROA | 0.012 |
SkinSen | 0.925 |
Carcinogencity | 0.054 |
EI | 0.944 |
Respiratory | 0.06 |
NR-Aromatase | 0.654 |
Antiviral | No |
Prediction | 0.657268 |